[Treatment of systemic mycosis (author's transl)].
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001555:Benzene Derivatives / Q000009:adverse effects / Q000627:therapeutic use; D003596:Cytosine / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions; D005461:Fluorine / Q000627:therapeutic use; D005840:Gentian Violet / Q000627:therapeutic use; D006660:Histoplasmosis / Q000188:drug therapy; D006801:Humans; D007049:Iatrogenic Disease; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects; D009181:Mycoses / Q000139:chemically induced / Q000188:drug therapy*; D010866:Natamycin / Q000627:therapeutic use; D009761:Nystatin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000935:Antifungal Agents; D001555:Benzene Derivatives; D007093:Imidazoles; D007166:Immunosuppressive Agents; D013449:Sulfonamides; D009761:Nystatin; D005461:Fluorine; D003596:Cytosine; D010866:Natamycin; D005840:Gentian Violet
Therapie der Systemmykosen.